Compare BridgeBio Pharma Inc (BBIO) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Waste Management, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Waste Management, Inc. trades at $225.9 (market cap $90.68B). The key difference: Waste Management, Inc. is far larger — about 5.5× BridgeBio Pharma Inc's market cap, and Waste Management, Inc. pays a 1.56% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | WM | |
|---|---|---|
Market Cap | $16.36B | $90.68B |
Sector | Health | Industrials |
52-Week High | $90.17 | $246.51 |
52-Week Low | $47.29 | $196.77 |
Enterprise Value | $18.14B | $113.47B |
Dividend Yield | — | 1.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
